The table below shows NOVAVAX INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$32.42M
-$185.50M
-$83.56M
-$325.59M
-$88.51M
$663.09M
Capital expenditure
-
-
-
-
-
-
Investing cash flow
-$28.36M
-$73.32M
-$7.25M
-$23.56M
-$16.83M
$141.61M
Dividends paid
-
-
-
-
NVAX operating cash flow (10-K history)
NOVAVAX INC reported operating cash flow of -$244.63M for fiscal year 2025. That is down 180.3% from -$87.26M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$258.77M (FY 2016) to -$244.63M. Figures come from the company's audited annual reports as filed with the SEC.
